An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial (Q35122823)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial |
scientific article |
Statements
An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial (English)
P Noel Barrett
Nina Wressnigg
Maikel V W van der Velden
Daniel Portsmouth
Wolfgang Draxler
Maria O'Rourke
Stephen Hall
Andrew Redfern
Gerald Aichinger
24 December 2014
1 reference
1 reference